What is the recommended dose of Metronidazole (Flagyl) for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole Dosing for Adults

Recommended Doses by Indication

The recommended dose of metronidazole varies significantly by indication, with trichomoniasis requiring 500 mg orally twice daily for 7 days (preferred) or 2 g as a single dose, bacterial vaginosis requiring 500 mg orally twice daily for 7 days, and Clostridioides difficile infection requiring 500 mg orally three times daily for 10 days only when vancomycin or fidaxomicin are unavailable. 1, 2, 3, 4

Trichomoniasis

  • First-line regimen: Metronidazole 500 mg orally twice daily for 7 days 2, 3

    • This 7-day regimen achieves superior cure rates (89% vs 81%) compared to single-dose therapy and should be the preferred treatment 5
    • The 7-day course minimizes reinfection by protecting the patient long enough for sexual contacts to obtain treatment 4
  • Alternative regimen: Metronidazole 2 g orally as a single dose 2, 3, 4

    • Single-dose treatment can assure compliance, especially if administered under supervision 4
    • However, recent high-quality RCT data demonstrates the 7-day regimen is significantly more effective (11% vs 19% treatment failure, p<0.0001) 5
  • Critical partner management: Treat all sexual partners simultaneously regardless of symptoms 2, 3

Bacterial Vaginosis

  • Metronidazole 500 mg orally twice daily for 7 days 3
  • Alternative: Metronidazole gel 0.75%, one full applicator (5 g) intravaginally once daily for 5 days 3
  • Important caveat: The 2 g single-dose regimen has lower efficacy for bacterial vaginosis and is not preferred 3

Clostridioides difficile Infection (CDI)

  • Metronidazole 500 mg orally three times daily for 10 days 1, 6
  • Critical limitation: Use ONLY for non-severe CDI when vancomycin (125 mg four times daily) or fidaxomicin (200 mg twice daily) are unavailable 1, 6
  • Metronidazole is inferior to vancomycin for CDI (cure rates 84% vs 97%, p<0.006) and has been downgraded to weak recommendation status 1, 6
  • Avoid repeated or prolonged courses due to risk of cumulative and potentially irreversible neurotoxicity 1, 6

Fulminant CDI

  • Metronidazole 500 mg intravenously every 8 hours PLUS oral/rectal vancomycin 1
  • Metronidazole should never be used as monotherapy for severe or fulminant CDI 6
  • IV metronidazole is added because it achieves therapeutic concentrations in inflamed colon, especially when ileus impairs oral vancomycin delivery 1

Amebiasis

  • Acute intestinal amebiasis: 750 mg orally three times daily for 5-10 days 4
  • Amebic liver abscess: 500-750 mg orally three times daily for 5-10 days 4

Anaerobic Bacterial Infections

  • Standard dose: 7.5 mg/kg every 6 hours (approximately 500 mg for a 70 kg adult) 4
  • Maximum daily dose: 4 g per 24 hours 4
  • Usual duration: 7-10 days, though bone/joint, lower respiratory tract, and endocardium infections may require longer treatment 4

Special Population Adjustments

Pregnancy

  • Trichomoniasis in 2nd/3rd trimester: 2 g orally as single dose 2, 3, 4
  • Contraindicated in first trimester 3, 4
  • For pregnant patients requiring treatment, the one-day course should not be used as it results in higher serum levels that can reach fetal circulation 4

Severe Hepatic Disease

  • Administer doses below usual recommendations cautiously 4
  • Close monitoring of plasma metronidazole levels and toxicity is recommended 4
  • Patients with severe hepatic disease metabolize metronidazole slowly, resulting in accumulation 4

Renal Failure

  • No specific dose reduction required in anuric patients 4
  • Accumulated metabolites are rapidly removed by dialysis 4

Elderly Patients

  • Monitor serum levels as pharmacokinetics may be altered 4
  • Adjust dosage accordingly based on monitoring 4

Critical Treatment Considerations

Treatment Duration and Extension

  • Most patients respond within 10 days, but some (particularly those on metronidazole for CDI) may have delayed response 1, 6
  • If symptoms are improving but not resolved by day 10, consider extending treatment to 14 days 1
  • Only 71% of CDI patients respond within 6 days on metronidazole 6

Treatment Failure Management

  • For trichomoniasis treatment failure: Re-treat with metronidazole 500 mg twice daily for 7 days 2, 3
  • For repeated failure: Metronidazole 2 g once daily for 3-5 days 2, 3
  • Always exclude reinfection from untreated partners before assuming true treatment failure 2, 3

Factors Associated with Higher Failure Rates

  • Age >60 years 6
  • Fever, hypoalbuminemia, or peripheral leukocytosis 6
  • ICU admission 6
  • Abnormal abdominal CT imaging (for CDI) 6

Common Pitfalls to Avoid

Critical Errors

  • Never use metronidazole vaginal gel for trichomoniasis—it achieves <50% efficacy and is only approved for bacterial vaginosis 2, 3
  • Never use metronidazole as monotherapy for severe or fulminant CDI 1, 6
  • Never skip partner treatment for trichomoniasis, even if asymptomatic 2, 3
  • Never prescribe repeated or prolonged courses for CDI due to neurotoxicity risk 1, 6

Important Warnings

  • Instruct patients to avoid alcohol during treatment and for 24 hours afterward due to disulfiram-like reaction 3
  • Most common side effects: nausea (23%), headache (7%), vomiting (4%) 5
  • When repeat courses are required, allow 4-6 weeks interval between courses and reconfirm infection presence 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Trichomoniasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metronidazole Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metronidazole Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.